Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.10 - Poster Session 1 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 57
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.10-026 - Validation of EGFR Mutation Testing Using Cytology Specimens in Non-small Cell Lung Carcinoma: Multi-institutional study of 128 cases in Korea
09:30 - 09:30 | Author(s): K. Min
- Abstract
Loading...
-
+
P1.24 - Poster Session 1 - Clinical Care
- Type: Poster Session
- Track: Supportive Care
- Presentations: 53
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.24-013 - Prophylaxis against pulmonary thromboembolism with unfractionated heparin for the patients undergoing pulmonary resection for lung cancer
09:30 - 09:30 | Author(s): T. Takemoto
- Abstract
Loading...
-
+
P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.05-010 - Several receptor tyrosine kinase is activated but orchestrated by EGFR in EGFR-TKI acquired resistant lung adenocarcinoma cells with EGFR mutation
09:30 - 09:30 | Author(s): K. Suda
- Abstract
Loading...
-
+
P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 50
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.06-033 - Identification f IGF-1R activation as a candidate molecular target in KRAS-mutated lung cancer
09:30 - 09:30 | Author(s): H. Mizuuchi
- Abstract
Loading...
-
+
O15 - NSCLC - Chemotherapy II
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:G. Richardson
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside Auditorium A, Level 1
-
+
O15.05 - Randomized Phase III Trial of S-1 plus Cisplatin versus Docetaxel plus Cisplatin for Advanced Non-Small-Cell Lung Cancer (TCOG0701): Subgroup Analysis.
11:15 - 11:25 | Author(s): O. Ishimoto
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.10 - Poster Session 3 - Chemotherapy
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 55
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.10-012 - Feasibility study of docetaxel and bevacizumab in elderly patients with advanced nonsquamous non-small cell lung cancer: Thoracic Oncology Research Group (TORG) 1014.
09:30 - 09:30 | Author(s): M. Yomota
- Abstract
Loading... -
+
P3.10-018 - An administration timing and dosage of the gefitinib in the advanced non-small-cell lung cancer patients with epidermal growth factor receptor mutation
09:30 - 09:30 | Author(s): S. Fujimoto
- Abstract
Loading... -
+
P3.10-045 - Combination chemotherapy with bevacizumab, docetaxel and carboplatin for chemotherapy-naive patients with non-squamous cell lung carcinoma: Phase II study.
09:30 - 09:30 | Author(s): M. Matsumoto
- Abstract
Loading...
-
+
P3.24 - Poster Session 3 - Supportive Care
- Type: Poster Session
- Track: Supportive Care
- Presentations: 54
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.24-014 - Multicenter study of zoledronic acid in lung cancer patients with bone metastasis. Thoracic Oncology Research Group (TORG) 1017.
09:30 - 09:30 | Author(s): Y. Hosomi
- Abstract
Loading...